Home › Compare › BIOR vs MCD

BIOR vs MCD: Dividend Comparison 2026

BIOR yields 909.09% · MCD yields 2.35%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 BIOR wins by $8252648.13M in total portfolio value
10 years
BIOR
BIOR
● Live price
909.09%
Share price
$0.22
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$8252648.21M
Annual income
$6,784,560,004,057.53
Full BIOR calculator →
MCD
McDonald's Corporation
● Live price
2.35%
Share price
$308.53
Annual div
$7.26
5Y div CAGR
42.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$78.5K
Annual income
$26,227.70
Full MCD calculator →

Portfolio growth — BIOR vs MCD

📍 BIOR pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodBIORMCD
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, BIOR + MCD cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
BIOR pays
MCD pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

BIOR
Annual income on $10K today (after 15% tax)
$77,272.73/yr
After 10yr DRIP, annual income (after tax)
$5,766,876,003,448.90/yr
MCD
Annual income on $10K today (after 15% tax)
$200.01/yr
After 10yr DRIP, annual income (after tax)
$22,293.55/yr
At 15% tax rate, BIOR beats the other by $5,766,875,981,155.36/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of BIOR + MCD for your $10,000?

BIOR: 50%MCD: 50%
100% MCD50/50100% BIOR
Portfolio after 10yr
$4126324.14M
Annual income
$3,392,280,015,142.62/yr
Blended yield
82.21%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MCD right now

BIOR
Analyst Ratings
1
Buy
Consensus: Buy
Altman Z
-109.2
Piotroski
4/9
MCD
Analyst Ratings
37
Buy
23
Hold
1
Sell
Consensus: Buy
Price Target
$351.76
+14.0% upside vs current
Range: $320.00 — $385.00
Altman Z
4.9
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

BIOR buys
0
MCD buys
0
No recent congressional trades found for BIOR or MCD in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricBIORMCD
Forward yield909.09% ✓2.35%
Annual dividend / share$2.00$7.26 ✓
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%42.3% ✓
Portfolio after 10y$8252648.21M ✓$78.5K
Annual income after 10y$6,784,560,004,057.53 ✓$26,227.70
Total dividends collected$8138900.96M ✓$58.5K
Payment frequencyquarterlyquarterly
SectorStockConsumer Discretionary
Analyst consensusBuyBuy

Year-by-year: BIOR vs MCD ($10,000, DRIP)

YearBIOR PortfolioBIOR Income/yrMCD PortfolioMCD Income/yrGap
1← crossover$101,609$90,909.09$10,815$334.85+$90.8K → BIOR
2$972,011$863,288.79$11,826$491.71+$960.2K → BIOR
3$8,758,157$7,718,105.75$13,123$730.06+$8.75M → BIOR
4$74,364,546$64,993,317.91$14,853$1,100.07+$74.35M → BIOR
5$595,318,755$515,748,691.06$17,257$1,690.61+$595.30M → BIOR
6$4,495,664,203$3,858,673,134.79$20,752$2,667.01+$4495.64M → BIOR
7$32,043,550,537$27,233,189,840.42$26,103$4,354.83+$32043.52M → BIOR
8$215,696,715,677$181,410,116,602.38$34,794$7,437.78+$215696.68M → BIOR
9$1,372,045,052,584$1,141,249,566,809.58$49,926$13,461.60+$1372045.00M → BIOR
10$8,252,648,210,323$6,784,560,004,057.53$78,550$26,227.70+$8252648.13M → BIOR

BIOR vs MCD: Complete Analysis 2026

BIOR — Stock

Biora Therapeutics, Inc., a biotechnology company, engages in developing oral biotherapeutics. The company's targeted therapeutics program uses an ingestible smart capsule for targeted delivery of therapeutics in the gastrointestinal (GI) tract to enhance the treatment of inflammatory bowel diseases; and systemic therapeutics program uses an ingestible capsule for needle-free delivery of biotherapeutics directly into the intestinal mucosa for enhanced systemic uptake. It is also developing diagnostics devices to help characterize the GI tract and diagnose GI diseases, such as small intestine bacterial overgrowth through the development of various technologies to diagnose at the site of the disease. The company was formerly known as Progenity, Inc. and changed its name to Biora Therapeutics, Inc. in April 2022 to reflect its focus on its therapeutics pipeline. Biora Therapeutics, Inc. was founded in 2010 and is headquartered in San Diego, California.

Full BIOR Calculator →

MCD — Consumer Discretionary

McDonald's Corporation operates and franchises McDonald's restaurants in the United States and internationally. Its restaurants offer hamburgers and cheeseburgers, chicken sandwiches and nuggets, wraps, fries, salads, oatmeal, shakes, desserts, sundaes, soft serve cones, bakery items, soft drinks, coffee, and beverages and other beverages, as well as breakfast menu, including biscuit and bagel sandwiches, breakfast burritos, hotcakes, and other sandwiches. As of December 31, 2021, the company operated 40,031 restaurants. McDonald's Corporation was founded in 1940 and is headquartered in Chicago, Illinois.

Full MCD Calculator →
📬

Get this BIOR vs MCD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

BIOR vs SCHDBIOR vs JEPIBIOR vs OBIOR vs KOBIOR vs MAINBIOR vs YUMBIOR vs QSRBIOR vs SBUX

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.